EraCal

company

About

EraCal Therapeutics develops drugs to treat different diseases.

  • 1 - 10

Details

Last Funding Type
Seed
Industries
Biotechnology,Pharmaceutical
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

EraCal Therapeutics is a Swiss biotech company committed to cutting-edge science and medicine. EraCal develops drugs to treat different diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
Fr1M
EraCal has raised a total of Fr1M in funding over 2 rounds. Their latest funding was raised on Oct 18, 2019 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 18, 2019 Seed 1 Detail
Jun 4, 2019 Seed Fr1M 1 Life Sciences Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
1
EraCal is funded by 1 investors. Life Sciences Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Life Sciences Fund Seed